Sirnaomics seals $105M Series D financing round


Sirnaomics Inc., a Gaithersburg biopharmaceutical company in discovery and development of RNAi therapeutics, sealed its $105 million Series D financing round, the firm announced. The funding round was co-led by existing investor Rotating Boulder Fund, new investor Walvax Biotechnology Co., Ltd. and ...

Read More »